| Market Capitalization (Millions $) |
1 |
| Shares
Outstanding (Millions) |
2 |
| Employees |
72 |
| Revenues (TTM) (Millions $) |
6 |
| Net Income (TTM) (Millions $) |
-20 |
| Cash Flow (TTM) (Millions $) |
-3 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Avinger Inc is a medical device company that focuses on providing innovative solutions in the field of vascular medicine. The company develops and commercializes products for the treatment of chronic total occlusions (CTOs), which are blockages in the blood vessels that can lead to various cardiovascular diseases.
Avinger's flagship product is the Pantheris™ Lumivascular atherectomy system, which is designed to remove plaque from blood vessels while avoiding damage to the vessel walls. The system incorporates real-time intravascular imaging, allowing physicians to navigate through the occlusions with precision and improve the safety and efficacy of the procedure.
In addition to Pantheris, Avinger offers a range of complementary products and devices for the treatment of peripheral artery disease (PAD) and other vascular conditions. The company aims to improve patient outcomes and reduce the need for more invasive surgical interventions through its minimally invasive and image-guided technologies.
Avinger Inc is headquartered in Redwood City, California, and its products are used by physicians and hospitals worldwide. The company is committed to advancing the field of vascular medicine through continuous research, development, and innovation.
Company Address: 400 Chesapeake Drive Redwood City 94063 CA
Company Phone Number: 241-7900 Stock Exchange / Ticker: NASDAQ AVGR
|
1.83%